Abstract
Parkinson's disease (PD) exhibits symptoms of motor dysfunction such as tremor, akinesia and rigidity. Agents that selectively disrupt or destroy catecholaminergic systems, such as reserpine, methamphetamine, 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine, have been used to develop PD models and to study the animal behavior like catalepsy, akinesia, swim-test, etc. The major apprehension while working with these chemicals is their irreversible neuro-toxic effect. Haloperidol is a classical antipsychotic drug, which produces extra-pyrimidal Parkinson's symptoms (EPS). Measuring catalepsy and akinesia in the treated mice monitored the haloperidol-induced EPS. Alternatively, swimming disability was tested as a new parameter to monitor haloperidol-induced EPS. The results showed that the restoration of swimming disability in haloperidol-induced L-dopa and caffeine pre-treated mice could be used as pre-clinical model to study PD.
References
Oct 2, 1991·European Journal of Pharmacology·C J SchmidtV L Taylor
Jan 3, 1991·European Journal of Pharmacology·S FerréN E Andén
Sep 1, 1989·Pharmacology, Biochemistry, and Behavior·F B WeihmullerJ P Bruno
Feb 15, 1988·Neuroscience Letters·F B WeihmullerJ P Bruno
Feb 1, 1987·Journal of the Neurological Sciences·G A DonnanP Rowe
Jun 1, 1974·European Journal of Pharmacology·B Costall, R J Naylor
Oct 1, 1980·The American Journal of Psychiatry
Sep 1, 1993·Pharmacology, Biochemistry, and Behavior·P M CarveyJ Z Fields
Apr 1, 1996·Progress in Neuro-psychopharmacology & Biological Psychiatry·E AllevaL Aloe
Jul 1, 1997·Neuroscience and Biobehavioral Reviews·W J Schmidt, B D Kretschmer
Nov 5, 1997·Trends in Pharmacological Sciences·P J RichardsonP G Jenner
Jan 1, 1997·Life Sciences·T KobayashiY Oshima
May 13, 1998·Molecular Psychiatry·P Seeman, T Tallerico
Dec 5, 1998·Brain Research·H HaginoK Torii
Dec 14, 1999·Behavioural Brain Research·S StoltzT Schallert
May 24, 2001·Progress in Neuro-psychopharmacology & Biological Psychiatry·A D Crocker, K M Hemsley
Jun 23, 2001·Pharmacology, Biochemistry, and Behavior·K R PowellS G Holtzman
Sep 29, 2001·The European Journal of Neuroscience·K J WhiteheadP Jenner
Oct 30, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M L WadenbergS Kapur
Jul 13, 2002·Brain Research·Zitao ZhuSteven W Johnson
Oct 31, 2003·Psychopharmacology·George E Jaskiw, Rodolfo Bongiovanni
Feb 26, 2004·The Annals of Pharmacotherapy·Oscar P Dall'IgnaDiogo R Lara
May 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Mark E JacksonBita Moghaddam
Apr 29, 2005·Neuropharmacology·Sen WangGang Hu
Jun 9, 2005·Behavioural Brain Research·Reena HaobamKochupurackal P Mohanakumar
Aug 2, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Alexander KuzminBertil B Fredholm
Jan 13, 2006·The Journal of Biological Chemistry·Kotaro HattoriShigeki Yuasa
Oct 27, 2006·European Journal of Pharmacology·Mahendra BishnoiShrinivas K Kulkarni
Jun 26, 2007·Physiology & Behavior·Gilberto FisoneEmanuela Santini
Citations
May 29, 2013·Pharmacology & Therapeutics·Elaine Cristina Gavioli, Girolamo Calo'
Mar 25, 2014·Expert Opinion on Drug Delivery·Shadab MdJaved Ali
Dec 26, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Shadab MdJaved Ali
Aug 6, 2009·Neuroscience Letters·Pratibha Mehta LuthraJ B Senthil Kumar
Feb 3, 2012·Genes, Brain, and Behavior·Y ChenC V Vorhees
Aug 17, 2010·Neuroscience Letters·Sandeep Kumar BarodiaPratibha Mehta Luthra
Mar 23, 2010·Bioorganic & Medicinal Chemistry·Chandra Bhushan MishraPratibha Mehta Luthra
Dec 22, 2014·Neuroscience Letters·Rita KumariPratibha Mehta Luthra
Oct 29, 2013·Neuroscience Letters·Namrata KumariPratibha Mehta Luthra
Jul 16, 2014·PloS One·Tam DuongDaewoong Jo
Apr 20, 2018·Current Drug Discovery Technologies·Rajalakshmi RukmangathenPrasanna Raju Yalavarthi
Dec 12, 2012·Toxicology and Industrial Health·Bhaskar BalajiAnil Kumar
May 9, 2015·Expert Review of Neurotherapeutics·Gulam MustafaJaved Ali
Jan 6, 2021·Chemistry and Physics of Lipids·Muhammad Usama AshharSanjula Baboota
Apr 6, 2021·The European Journal of Neuroscience·Isabelle WakuAmanda R de Oliveira
Sep 1, 2021·Journal of Biochemical and Molecular Toxicology·Rajnish SrivastavaVaibhav Rathore